title: Epidemiological African day for evaluation of patients at risk of venous thrombosis in acute hospital care settings.
abstract: BACKGROUND
  This study aimed to identify patients at risk for venous thromboembolism (VTE) among all patients hospitalised, and to determine the proportion of at-risk hospital patients who received effective types of VTE prophylaxis in sub-Saharan Africa (SSA).
  
  
  METHODS
  A multinational, observational, cross-sectional survey was carried out on 1 583 at-risk patients throughout five SSA countries.
  
  
  RESULTS
  The prevalence of VTE risk was 50.4% overall, 62.3% in medical and 43.8% in surgical patients. The proportion of at-risk patients receiving prophylaxis was 51.5% overall, 36.2% in medical and 64% in surgical patients. Low-molecular weight heparin was the most frequently used prophylactic method in 40.2% overall, 23.1% in medical and 49.9% in surgical patients.
  
  
  CONCLUSIONS
  This study showed a high prevalence of VTE risk among hospitalised patients and that less than half of all at-risk patients received an American College of Clinical Pharmacy-recommended method of prophylaxis.
  
  
  CONCLUSIONS
  Recommended VTE prophylaxis is underused in SSA.
authors.affiliation: Department of Cardiology, General Hospital, Yaoundé, Cameroon.
authors.forename: Samuel
authors.initials: S
authors.lastname: Kingue
authors.affiliation: Department of Internal Medicine, Clinic Ngaliema, Kinshasa, DRC.
authors.forename: Limbole
authors.initials: L
authors.lastname: Bakilo
authors.affiliation: Department of Anaesthesiology and Reanimation, Hospital Gynéco obstetrique et Pédiatrique, Yaoundé, Cameroon.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Ze Minkande
authors.affiliation: SA NOFI, North-East Africa, Lagos, Nigeria. fifen.inoussa@sanofi.com.
authors.forename: Inoussa
authors.initials: I
authors.lastname: Fifen
authors.affiliation: Orthopaedic Department, Princess Marina Hospital, Gaborone, Botswana.
authors.forename: Yash  Pal
authors.initials: Y
authors.lastname: Gureja
authors.affiliation: Orthopaedist, Antananarivo, Madagascar.
authors.forename: Henri Jean Claude
authors.initials: HJ
authors.lastname: Razafimahandry
authors.affiliation: Department of Neurology, Lagos University Teaching Hospital, Lagos, Nigeria.
authors.forename: Njideka
authors.initials: N
authors.lastname: Okubadejo
authors.affiliation: Department of Internal Medicine, Clinic Ngaliema, Kinshasa, DRC.
authors.forename: Richard
authors.initials: R
authors.lastname: Mvuala
authors.affiliation: Department of Cardiology, Lagos University Teaching Hospital, Lagos, Nigeria.
authors.forename: D A
authors.initials: DA
authors.lastname: Oke
authors.affiliation: Orthopaedic Department, Hopital du Caisse nationale de prévoyance Sociale, Yaoundé Cameroon.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Manga
authors.affiliation: Department of Anaesthesiology and Reanimation, Mother and Child Hospital, Antananarivo, Madagascar.
authors.forename: Tovohery
authors.initials: T
authors.lastname: Rajaonera
authors.affiliation: National Orthopaedic Hospital, Enugu, Nigeria.
authors.forename: Cajetan
authors.initials: C
authors.lastname: Nwadinigwe
authors.affiliation: Orthopaedic Department, Clinic Ngaliema, Kinshasa, DRC.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Pay Pay
authors.affiliation: Department of Cardiology, Mother and Child Hospital, Antananarivo, Madagascar.
authors.forename: Nirina
authors.initials: N
authors.lastname: Rabearivony
mesh_terms: D000328:Adult; D017954:Africa South of the Sahara / Q000453:epidemiology; D000925:Anticoagulants / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006761:Hospitals / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D000925:Anticoagulants